Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can Now We Need to Start Pulling! | Clin Infect Dis;73(11): e4451-e4453, 2021 12 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can Now We Need to Start Pulling!

Rex, John H; Outterson, Kevin.

Affiliation

Rex JH; F2G Limited, Eccles, Cheshire, United Kingdom.
Outterson K; McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, Texas, USA.

Clin Infect Dis ; 73(11): e4451-e4453, 2021 12 06.

Article in En | MEDLINE | ID: mdl-32584949

Subject(s)

Anti-Bacterial Agents; Anti-Bacterial Agents/therapeutic use; Humans

Key words

FDA; antibacterial agents; antibiotic innovation; antibiotic resistance

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Bacterial Agents Limits: Humans Language: En Journal: Clin Infect Dis Year: 2021 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Bacterial Agents Limits: Humans Language: En Journal: Clin Infect Dis Year: 2021 Document type: Article